Trademark: 79353523
Word
BIONTECH
Status Date
Tuesday, September 19, 2023
Registration Number
7166547
Registration Date
Tuesday, September 19, 2023
Filing Date
Tuesday, December 28, 2021
Published for Opposition
Tuesday, July 4, 2023
9 Downloadable mobile applications for enabling healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; downloadable computer software for enabling healthcare professionals and patients to access information on pharmaceutical, medical and vaccine products and services; downloadable e-commerce computer software for enabling users to perform electronic business transactions via a global computer network
5 Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Chemical reagents used for medical purposes; Biochemical reagents used for purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; diagnostic preparations for clinical or medical laboratory use
35 Business advisory services in the field of electronic commerce; providing business information in the field of electronic commerce; providing business information, namely, customer information on pharmaceutical and medical products through an on-line computer network; wholesale and retail store services featuring pharmaceutical products, medicinal preparations, and medical supplies
1 Chemicals for use in pharmaceutical industry; active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; adjuvants for use in manufacture of vaccines; nucleic acids, proteins and peptides for laboratory use; diagnostic preparations for scientific or research use other than for medical purposes
44 Medical, hygienic and beauty care; healthcare services; provision of medical information and services; provision of medical information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical products, medical diseases and disorders and related treatments via the Internet; medical services in the field of gene therapy; medical services in the field of cell therapy; medical and health care services; medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; medical and pharmaceutical consultation; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes
10 Medical diagnostic devices for analysis of body fluids and biopsies for diagnosis and monitoring of cancer, infectious diseases, and immunological diseases; medical diagnostic devices for analysis of body fluids and biopsies for patient stratification
42 medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; providing medical and scientific research information, consultancy, and advisory services, all in the fields of medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; medical and scientific research services by compiling data for clinical trials and drug admission
The mark consists of stylized letters reading "BIONTECH" wherein the "B", "I", "O", "E", "C" and "H" appear in dark green color and the "N" and "T" appear in light green color.
The color(s) dark green and light green is/are claimed as a feature of the mark.
Jan 8, 2024
Final Decision Transaction Processed By Ib
Dec 21, 2023
Final Disposition Notice Sent To Ib
Dec 21, 2023
Final Disposition Processed
Dec 19, 2023
Final Disposition Notice Created, To Be Sent To Ib
Sep 25, 2023
Teas Change Of Correspondence Received
Sep 25, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 25, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 19, 2023
Notice Of Registration Confirmation Emailed
Sep 19, 2023
Registered-Principal Register
Jul 11, 2023
Notification Processed By Ib
Jul 4, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 4, 2023
Published For Opposition
Jun 20, 2023
Notification Of Possible Opposition Sent To Ib
Jun 21, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 14, 2023
Notification Of Notice Of Publication E-Mailed
May 26, 2023
Approved For Pub - Principal Register
May 3, 2023
Examiner's Amendment Entered
May 3, 2023
Notification Of Examiners Amendment E-Mailed
May 3, 2023
Examiners Amendment E-Mailed
May 3, 2023
Examiners Amendment -Written
Mar 31, 2023
Teas/Email Correspondence Entered
Mar 31, 2023
Correspondence Received In Law Office
Mar 31, 2023
Teas Response To Office Action Received
Feb 15, 2023
Refusal Processed By Ib
Jan 20, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Jan 20, 2023
Refusal Processed By Mpu
Nov 15, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Nov 14, 2022
Non-Final Action Written
Nov 11, 2022
Application Filing Receipt Mailed
Nov 7, 2022
Assigned To Examiner
Nov 7, 2022
New Application Office Supplied Data Entered
Nov 1, 2022
Limitation From Original Application Entered
Oct 27, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
